Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

WisdomTree, Inc. (WT)

Security Brokers, Dealers & Flotation Companies

https://www.wisdomtree.com

WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.

250 WEST 34TH STREET, 3RD FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/15/1992

Market Cap

1,486,670,240

Shares Outstanding

150,340,000

Weighted SO

150,335,358

Total Employees

N/A

Upcoming Earnings

07/26/2024

Similar Tickers

VKI --.--%

VKQ --.--%

VCV --.--%

VCTR --.--%

VGM --.--%

IQI --.--%

VMO --.--%

CXE --.--%

KTF --.--%

Beta

1.4830

Last Div

0.1200

Range

6.06-12.02

Chg

-0.1900

Avg Vol

1456327

Mkt Cap

1486670240

Exch

NYSE

Country

US

Phone

212-801-2080

DCF Diff

3.4646

DCF

6.3454

Div Yield

0.0123

P/S

3.8601

EV Multiple

14.1932

P/FV

2.4875

Div Yield %

1.2257

P/E

19.4692

PEG

2.6558

Payout

0.2758

Current Ratio

3.0075

Quick Ratio

3.6572

Cash Ratio

1.5641

DSO

40.4331

DIO

-209.5607

Op Cycle

-169.1276

DPO

65.8948

CCC

-235.0224

Gross Margin

0.7512

Op Margin

0.2965

Pretax Margin

0.2620

Net Margin

0.1918

Eff Tax Rate

0.2476

ROA

0.0765

ROE

0.1468

ROCE

0.1297

NI/EBT

0.7319

EBT/EBIT

0.8837

EBIT/Rev

0.2965

Debt Ratio

0.2865

D/E

0.4782

LT Debt/Cap

0.3228

Total Debt/Cap

0.3235

Int Coverage

10.0644

CF/Debt

0.3499

Equity Multi

1.6693

Rec Turnover

9.0273

Pay Turnover

5.5391

Inv Turnover

-1.7417

FA Turnover

305.6659

Asset Turnover

0.3991

OCF/Share

0.6586

FCF/Share

0.6348

Cash/Share

1.0022

OCF/Sales

0.2512

FCF/OCF

0.9639

CF Coverage

0.3499

ST Coverage

114.2184

CapEx Coverage

27.7201

Div&CapEx Cov

4.0546

P/BV

2.4875

P/B

2.4875

P/S

3.8601

P/E

19.4692

P/FCF

15.9423

P/OCF

14.8653

P/CF

14.8653

PEG

2.6558

P/S

3.8601

EV Multiple

14.1932

P/FV

2.4875

DPS

0.1200

Latest Headlines (EST)

GlobeNewswire Inc. Jun 19, 01:00 Willis launches Zest Insurance, a digital revolution for Australian SMEs GlobeNewswire Inc. Jun 15, 19:46 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders GlobeNewswire Inc. Jun 15, 18:44 HAPPY FATHER’S DAY and $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: OPOF, PRA, SWTX and FLS Benzinga Jun 07, 19:56 NWTN Investors Have Opportunity to Join NWTN Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire Inc. Jun 06, 20:50 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brown-Forman Corporation - BF-B; BF-A GlobeNewswire Inc. Jun 02, 23:14 $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger – PRA, AXL, SWTX and VIGL Benzinga Jun 01, 23:42 $HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - PRA, AXL, SWTX and VIGL GlobeNewswire Inc. May 29, 06:00 Wolters Kluwer to acquire global legal software provider Brightflag GlobeNewswire Inc. May 24, 23:17 SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN GlobeNewswire Inc. May 24, 23:17 SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling van volwassen en pediatrische patiënten met NF1-PN GlobeNewswire Inc. May 24, 23:17 SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des patients adultes et pédiatriques atteints de NF1-PN GlobeNewswire Inc. May 24, 23:17 SpringWorks Therapeutics recibe un dictamen positivo del CHMP para el uso de mirdametinib en el tratamiento de la NF1-NP en pacientes adultos y pediátricos GlobeNewswire Inc. May 24, 23:17 SpringWorks Therapeutics: CHMP valuta positivamente Mirdametinib per il trattamento di pazienti adulti e pediatrici affetti da NF1-PN GlobeNewswire Inc. May 23, 01:16 Brompton Split Banc Corp. Renews At-the-Market Equity Program GlobeNewswire Inc. May 18, 22:42 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWTX, NVEE, CHTR, INZY on Behalf of Shareholders GlobeNewswire Inc. May 18, 22:41 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AXL, KRON, PRA, SWTX on Behalf of Shareholders GlobeNewswire Inc. May 17, 17:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – PRA, KRON, AXL, SWTX Benzinga May 16, 22:30 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - PRA, KRON, AXL, SWTX GlobeNewswire Inc. May 05, 23:42 Willis leverages Moody’s flood data and analytics in its risk modeling suite Benzinga May 02, 04:28 Parker-Hannifin Trims Outlook, But CEO Says Firm Ready To Handle Tariff Uncertainty

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.03 05/07/2024 04/26/2024 05/08/2024 05/22/2024
0.03 02/13/2024 02/02/2024 02/14/2024 02/28/2024
0.03 11/07/2023 10/23/2023 11/08/2023 11/22/2023
0.03 08/08/2023 07/26/2023 08/09/2023 08/23/2023
0.03 05/09/2023 04/28/2023 05/10/2023 05/24/2023
0.03 02/14/2023 02/03/2023 02/15/2023 03/01/2023
0.03 11/08/2022 10/28/2022 11/09/2022 11/23/2022
0.03 08/09/2022 11/30/-0001 08/10/2022 08/24/2022
0.03 05/10/2022 11/30/-0001 05/11/2022 05/25/2022
0.03 02/08/2022 11/30/-0001 02/09/2022 02/23/2022
0.03 11/09/2021 11/30/-0001 11/10/2021 11/24/2021
0.03 08/10/2021 11/30/-0001 08/11/2021 08/25/2021
0.03 05/11/2021 11/30/-0001 05/12/2021 05/26/2021
0.03 02/09/2021 11/30/-0001 02/10/2021 02/24/2021
0.03 11/10/2020 11/30/-0001 11/11/2020 11/25/2020
0.03 11/09/2020 11/30/-0001 11/30/-0001 11/30/-0001
0.03 08/11/2020 11/30/-0001 08/12/2020 08/26/2020
0.03 05/12/2020 11/30/-0001 05/13/2020 05/27/2020
0.03 02/11/2020 11/30/-0001 02/12/2020 02/26/2020
0.03 11/05/2019 11/30/-0001 11/06/2019 11/20/2019
0.03 08/06/2019 11/30/-0001 08/07/2019 08/21/2019
0.03 05/07/2019 11/30/-0001 05/08/2019 05/22/2019
0.03 02/12/2019 11/30/-0001 02/13/2019 02/27/2019
0.03 11/06/2018 11/30/-0001 11/07/2018 11/21/2018
0.03 08/07/2018 11/30/-0001 08/08/2018 08/22/2018
0.03 05/08/2018 11/30/-0001 05/09/2018 05/23/2018
0.03 02/13/2018 11/30/-0001 02/14/2018 02/28/2018
0.08 11/07/2017 11/30/-0001 11/08/2017 11/22/2017
0.08 08/07/2017 11/30/-0001 08/09/2017 08/23/2017
0.08 05/08/2017 11/30/-0001 05/10/2017 05/24/2017
0.08 02/13/2017 11/30/-0001 02/15/2017 03/01/2017
0.08 11/07/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.08 08/08/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.08 05/09/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.08 02/12/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.33 11/06/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.08 08/10/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.08 05/11/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.08 02/13/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.08 11/07/2014 11/30/-0001 11/30/-0001 11/30/-0001